Status:
UNKNOWN
Clinical Evaluation of the Use of Surgical Tube Technique Versus Hyaluronic AcidInjection in Reconstruction of the Interproximal Papilla
Lead Sponsor:
waleed mohammad sabry
Conditions:
the Clinical Effect of Surgical Tube Technique in Reconstruction of the Interproximal Papilla
Eligibility:
All Genders
25-40 years
Phase:
NA
Brief Summary
Restoring defective interdental papilla partially or totally in structure and function creates a challenge in dental field owing to the small working space and limited blood supply to the area. This ...
Detailed Description
The interdental papilla is the gingival portion that fills the proximal area under the contact between two adjacent teeth, where it is defined as gingival tissues extending from incisal tip of the pap...
Eligibility Criteria
Inclusion
- Highly motivated patients with papillary deficiency types II, according to Nordland and Tarnow 1998 classification will be selected, having at least one deficient papilla in the anterior region.
- Distance between the contact point and inter-proximal bone crest (CP-BC) of ≤ 7 mm and probing depth of ≤ 4 mm at the deficient papillary site (Abdelraouf etal. 2019).
- Patients with full mouth plaque index (PI) and gingival index (GI) scores should be between 0-1.
- Healthy patients free of any medical condition.
Exclusion
- ● Patients with medical conditions that may affect periodontal healing or regeneration.
- Patients with a history of allergic reactions, pregnant or breastfeeding females, smokers and alcoholics.
- Patients with current or previous drugs intake that may predispose to gingival enlargement.
- Patients under orthodontic treatment or had orthodontic treatment in the past six months.
- Carious teeth, proximal restorations or fixed prosthesis.
- Patients with a history of traumatic oral hygiene measures or periodontal surgeries over the last six months at the area of interest or having any scar tissue.
- Poor oral hygiene patients.
Key Trial Info
Start Date :
September 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05235477
Start Date
September 9 2021
End Date
December 1 2023
Last Update
February 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Waleed Mohammad Sabry
Cairo, Egypt